Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4860029 | 0.81 | KMT2A (0.34) | KMT2AATMTSHRALDH1A1 | |
| SCHEMBL4154528 | 0.81 | LMNA (0.44) | KMT2AATMTSHRALDH1A1CYP2D6 | |
| SCHEMBL19145906 | 0.79 | LMNA (0.39) | KMT2AATMTSHRCHRM2CHRM4 | |
| SCHEMBL11064065 | 0.79 | TSHR (0.36) | KMT2AATMTSHRALDH1A1 | |
| SCHEMBL12098030 | 0.77 | SMN1; SMN2 (0.36) | KMT2ATSHRALDH1A1MAPTLMNA | |
| SCHEMBL8578110 | 0.76 | TSHR (0.39) | KMT2AATMTSHRALDH1A1 | |
| SCHEMBL1403558 | 0.75 | TSHR (0.36) | KMT2AATMTSHRSLC1A2CHRM2 | |
| SCHEMBL2817068 | 0.74 | TSHR (0.38) | TSHRALDH1A1 | |
| SCHEMBL7351000 | 0.74 | MGAM (0.38) | KMT2AATMALDH1A1CYP2D6CYP2C9 | |
| SCHEMBL2030887 | 0.73 | LMNA (0.46) | KMT2AALDH1A1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4637985-A1 | A METHOD OF MAKING MICROCAPSULES COMPRISING A POLYMERIZED CORE AND THE USE OF THE SAME | Calyxia (FR) | 2025-10-29 | — | — | EP | disclosed |
| US-20250325947-A1 | DOUBLE EMULSION AND CAPSULES | CALYXIA (FR) | 2025-10-23 | — | — | US | disclosed |
| EP-3548521-B1 | METHOD TO PREPARE MICROCAPSULES AND MICROPARTICLES | CALYXIA (FR) | 2025-03-26 | — | — | EP | disclosed |
| EP-3600641-B1 | METHOD FOR PREPARING CAPSULES COMPRISING AT LEAST ONE WATER-SOLUBLE OR HYDROPHILIC SUBSTANCE AND CAPSULES OBTAINED THEREFROM | CALYXIA (FR) | 2025-02-12 | — | — | EP | disclosed |
| US-12186723-B2 | Method for preparing capsules comprising at least one volatile compound and capsules obtained therefrom | CALYXIA (FR) | 2025-01-07 | — | — | US | disclosed |
| WO-2024133578-A1 | A METHOD OF MAKING MICROCAPSULES COMPRISING A POLYMERIZED CORE AND THE USE OF THE SAME | CALYXIA (FR) | 2024-06-27 | — | — | WO | disclosed |
| EP-4389276-A1 | A METHOD OF MAKING MICROCAPSULES COMPRISING A POLYMERIZED CORE AND THE USE OF THE SAME | Calyxia (FR) | 2024-06-26 | — | — | EP | disclosed |
| US-20240024236-A1 | EMULSION COMPRISING SIZE-CONTROLLED DROPLETS | CALYXIA (FR) | 2024-01-25 | — | — | US | disclosed |
| WO-2023232993-A1 | DOUBLE EMULSION AND CAPSULES | CALYXIA (FR) | 2023-12-07 | — | — | WO | disclosed |
| EP-4286040-A1 | DOUBLE EMULSION AND CAPSULES | Calyxia (FR) | 2023-12-06 | — | — | EP | disclosed |
| US-7959990-B2 | Adjustment of liquid crystals; oligomers, dendrimers, or polymer in solution is applied to support; crosslinking by radiation or polarized light | ROLIC AG (CH) | 2011-06-14 | — | — | US | disclosed |
| US-20090202652-A1 | Photo-Responsive Microencapsulation Materials, Compositions and Methods of Use Thereof | SOLARBRE, INC. (US) | 2009-08-13 | — | — | US | disclosed |
| EP-1928979-B1 | FUNCTIONALIZED PHOTOREACTIVE COMPOUNDS | ROLIC AG (CH) | 2009-03-04 | — | — | EP | disclosed |
| US-20080274304-A1 | Functionalized Photoreactive Compounds | ROLIC AG (CH) | 2008-11-06 | — | — | US | disclosed |
| CN-101268168-A | Functionalized photoreactive compounds | ROLIC AG (CH) | 2008-09-17 | — | — | CN | disclosed |
| EP-1945344-A2 | PHOTO-RESPONSIVE MICROENCAPSULATION MATERIALS, COMPOSITIONS AND METHODS OF USE THEREOF | Solarbre, Inc. (US) | 2008-07-23 | — | — | EP | disclosed |
| WO-2007051198-A2 | PHOTO-RESPONSIVE MICROENCAPSULATION MATERIALS, COMPOSITIONS AND METHODS OF USE THEREOF | SOLARBRE, INC (US) | 2007-05-03 | — | — | WO | disclosed |
| EP-1764405-A1 | Functionalized photoreactive compounds | Rolic AG (CH) | 2007-03-21 | — | — | EP | disclosed |
| WO-2006101746-A1 | POSITIVE-WORKING, THERMALLY SENSITIVE IMAGEABLE ELEMENT | EASTMAN KODAK COMPANY (US) | 2006-09-28 | — | — | WO | disclosed |
| US-20060210917-A1 | Positive-working, thermally sensitive imageable element | KODAK POLYCHROME GRAPHICS LLC | 2006-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090202652-A1 | Photo-Responsive Microencapsulation Materials, Compositions and Methods of Use Thereof | LIPA, LIPE, CRYAA | KMT2A 4749/4885ATM 1376/4885TSHR 4608/4885 |
| US-20080274304-A1 | Functionalized Photoreactive Compounds | PCNA, PIN1, MAP1LC3C | KMT2A 3167/4885ATM 4135/4885TSHR 4847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.